MoneyWorks4Me

Hikal informs about investors meet

02 Sep 2026 Evaluate

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hikal has informed that Analysts and Institutional Investors (‘Participants’) are scheduled to visit the Company's Pune R&T centre and interact with the Company's officials, as per the details enclosed. Discussions will be based on publicly available information. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..